Predictive value of thyroid hormone assessment in septic patients in comparison with C-reactive protein  by Hosny, Mohamed et al.
The Egyptian Journal of Critical Care Medicine (2015) 3, 55–61The Egyptian College of Critical Care Physicians
The Egyptian Journal of Critical Care Medicine
http://ees.elsevier.com/ejccm
www.sciencedirect.comORIGINAL ARTICLEPredictive value of thyroid hormone assessment
in septic patients in comparison with C-reactive
protein* Corresponding author.
Peer review under responsibility of The Egyptian College of Critical
Care Physicians.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.ejccm.2015.11.001
2090-7303  2015 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V. All rights reserved.Mohamed Hosny *, Rania Rashad, Doaa Atef, Nashwa AbedCritical Care Department, Faculty of Medicine, Cairo University, EgyptReceived 8 December 2014; revised 28 May 2015; accepted 4 November 2015
Available online 19 November 2015KEYWORDS
Predictive value;
Sepsis;
Thyroid hormones;
C-reactive proteinAbstract Introduction: Thyroid dysfunction is associated with mortality in critically ill patients.
We investigated the predictive value of the thyroid hormone compared to CRP in septic patients.
Methods: 80 patients were included in a prospective, randomized study done in the critical care
department.
Results: FT3, FT4, and TSH levels on the ﬁfth day were below the normal range in 61.3%, 31.2%,
and 23.8% patients respectively. There was a signiﬁcant decrease in the FT3 level on admission com-
pared to the ﬁfth day (p< 0.001). By comparison of thyroid hormone levels in patients with sepsis,
severe sepsis and septic shock; we found the mean level of FT3 was lower in patients with septic shock
(1.3 ± 0.4 pg/ml) and severe sepsis (1.7 ± 0.2 pg/ml) as compared to patients with sepsis
(2.4 ± 1.2 pg/ml). The mean FT3 level increased in survivors (2.9 ± 1.03 pg/ml) compared to non
survivors (1.9 ± 0.89 pg/ml) (p< 0.001). Correlation of FT3 on the 5th day to CRP (r= 0.332,
p= 0.039), FT3 on 5th day to IL-6 (r= 0.339, p= 0.035) in non survivors. Correlation of FT3
on the 5th day to APACHE II (r= 0.359, p= 0.025) and SOFA score (r= 0.427, p= 0.007).
ROC curves indicated that FT3 on the 5th day had the greatest power for predicting ICU mortality
(sensitivity 87.2%and speciﬁcity 73.2%). CRP (sensitivity 100%and speciﬁcity 92.7%) is a better tool
than IL-6 (sensitivity 92.3% and speciﬁcity 80.5%) in predicting mortality in sepsis.
Conclusion: FT3 levels were negatively correlated to CRP and IL-6 levels as well as APACHE II,
SOFA scores. FT3 may be used as a marker of disease severity and a predictor of mortality.
 2015 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction
Sepsis, an infection induced systemic inﬂammation with delete-
rious host response to the pathogen, may often progress to
severe sepsis and ﬁnally to septic shock. Severe sepsis leads
to acute organ dysfunction secondary to documented or sus-
pected infection; the condition may progress to septic shock
56 M. Hosny et al.when hypotension develops that cannot be reversed with ﬂuid
resuscitation. Therefore, severe sepsis and septic shock are
recognized as major health concerns worldwide with increasing
incidence. Millions of people are affected around the world
each year, (killing one in four and often more) [1].
The assessment of infection response to antibiotics relies
mostly on the evolution of the same criteria used for diagnosis
[2]. Microbiological criteria are also of little help in the assess-
ment of response because of the long time needed to obtain
culture results. These uncertainties in the clinical decision-
making process have led investigators to study the inﬂamma-
tory cascade for potential objective markers of infection. These
biomarkers, could be used as surrogates of infection diagnosis;
C-reactive protein (CRP) is one of the most studied biomark-
ers in this regard [3], It has already been shown how a single
CRP measurement can help in the diagnosis of infection [4];
however there are some controversies concerning prognosis.
Furthermore, the serial determinations have also been found
to be useful in predicting infection as well as in monitoring
its response to treatment [5].
Abnormal ‘‘thyroid function test” results have often been
noticed in patients suffering from various infections, because
the thyroid hormone plays an important role in the adaptation
of metabolic function to stress and critical illness. Such alter-
ations in thyroid hormone levels are referred to as ‘‘nonthyroidal
illness syndrome (NTIS)”, characterized by low serum levels of
free and total triiodothyronine (T3) and high levels of reverse
T3 (rT3) accompanied by normal or low levels of thyroxin
(T4) and thyroid-stimulating hormone (TSH). NTIS can be
attributed to increased deiodination of thyroxine (T4) to reverse
T3 (rT3), rather than T3 and increased catabolism of T3 to 3, 3-
diiodothyronine (T2) [6]. With increasing severity of illness, low
total and free T4 and sometimes low TSH can be observed [7].
Thyroid dysfunction has also been found to be associated with
the mortality of patients admitted to the ICU [8].
Therefore, thyroid hormone is also an important predictor
in the mortality in patients with sepsis. The magnitude of the
thyroid function test result abnormalities seems to depend on
the severity and duration of illness, rather than the type of ill-
ness [9].
Researchers in some studies demonstrated that free tri-
iodothyronine (FT3) levels in non survivors were signiﬁcantly
lower than those in survivors in acute respiratory distress syn-
drome and prolonged mechanical ventilation [10], whereas
other researchers showed that there was no association
between FT3 levels and ICU patient outcomes [11]. Conﬂicting
results also were reported in terms of other indicators, such as
FT4 and TSH [12].
Here we investigated the relation between thyroid hormone
and mortality in patients with sepsis, severe sepsis and septic
shock in comparison with C reactive protein.2. Patient and methods
This prospective study was conducted in several Critical Care
Units of Kasr Al-Ainy Hospital, Cairo University. A total of
eighty patients, who were admitted to ICU with sepsis during
the period from October 2013 to March 2014, were included.
The patients were categorized into three groups: (i) sepsis
group included 36 patients with culture-proven or visually
identiﬁed infection accompanied by two or more of the follow-ing abnormalities (temperature >38.5 C or <36 C, heart
rate >90 beats/min, respiratory rate >20 breaths/min or
PaCO2 <32 mmHg and TLC count >12,000 cells/mm
3,
<4000 cells/mm3, or >10 percent immature (band) forms;
(ii) severe sepsis group included 23 patients with sepsis accom-
panied by organ failure or hypoperfusion (including oliguria
and altered mental status); (iii) septic shock group included
21 patients with severe sepsis accompanied by hypotension
(systolic blood pressure <90 mmHg or a fall off >40 mmHg
from the baseline in the absence of other causes of
hypotension).
Patients with the following criteria were excluded from our
study: (i) history of any thyroid diseases such as hyperthy-
roidism, hypothyroidism, thyroid tumors, and thyroid nodule
discovered by clinical examination on admission to the ICU;
(ii) pregnancy within the previous six months; (iii) intake of
drugs altering thyroid functions such as amiodarone, dopa-
mine, and phenytoin.
3. Data collection
Medical history with a special emphasis on the history of drug
intake or any thyroid disease of all patients was recorded. All
patients are subjected to full clinical examination including
vital signs assessment (heart rate, respiratory rate, blood pres-
sure, and temperature). Pan Cultures (blood, sputum, urine or
other suspected sites of infection) were collected on admission.
Blood samples were collected from each participant on the
day of admission (D1) and ﬁfth day after admission (D5) for
free triiodothyronine (FT3), free thyroxine (FT4), thyroid-
stimulating hormone (TSH), and C-reactive protein (CRP);
IL-6 was also determined on the day of admission. Informed
consent was obtained from the patient or his relatives. All
patients were followed up until discharge or death. Finally,
the patients were again divided into two groups: survivors
and non survivors.4. Measurements
Thyroid function tests (FT3, FT4 and TSH) were performed in
Chemical Pathology Unit, Kasr Al-Ainy Hospital on ELISA
Reader Stat Fax – 2100 using Enzyme Immunoassay Kits sup-
plied by BioCheck (323 Vintage Park Drive Kits Foster City,
CA 94404).
Following are the normal ranges of serum hormone con-
centrations: FT3 = 1.7–4.5 pmol/L, FT4 = 0.8–2 pmol/L,
and TSH= 0.3–5.50 mIU/L. Serum creatinine and albumin
levels were determined using chemistry auto analyzer (Hitachi
917) using Roche Diagnostics Kits. Serum CRP was measured
using the kits supplied by Teco Diagnostics (1268 N. Lakeview
Ave. Anaheim, CA 92807 USA. Serum IL-6 was measured
using Human IL-6 ELISA kit supplied by Ani Biotech (Orge-
nium Laboratories Business Unit).
5. Scoring systems
Our study included the calculation of scoring systems: Acute
Physiology and Chronic Health Evaluation (APACHE) II
and sequential organ failure assessment (SOFA) scores. They
allow an assessment of the severity of disease and provide an
estimate of in-hospital mortality.
Table 1 Level of FT3 in sepsis, severe sepsis and septic shock.
Group FT3 level
Mean ± SD
FT4 level
Mean ± SD
TSH level
Mean ± SD
Sepsis 2.4 ± 1.2 1.3 ± 0.8 2.3 ± 0.4
Severe sepsis 1.7 ± 0.2 1.0 ± 0.3 2.2 ± 0.3
Septic shock 1.3 ± 0.4 1.2 ± 0.2 2.2 ± 0.1
p value <0.001 0.5 0.7
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The APACHE score is a severity-of-disease classiﬁcation sys-
tem, one of several ICU scoring systems. It is applied within
24 hours of admission of a patient to an intensive care unit
(ICU): an integer score from 0 to 71 is computed based on sev-
eral variables: temperature, mean arterial pressure, heart rate,
respiratory rate oxygenation, arterial PH, serum sodium,
serum potassium serum creatinine, hematocrite, white blood
cell and Glasgow coma score.
Each variable is weighted from 0 to 4; with higher scores
corresponding to more severe diseases and a higher risk of
death. A score of 25 represents a predicted mortality of 50%
and a score of over 35 represents a predicted mortality of 80%.
7. B-SOFA score
The SOFA score was developed during a consensus conference
organized by the European Society of Intensive Care and
Emergency Medicine The SOFA score calculates a summary
value for the degree of dysfunction of six sets of organs: respi-
ratory (po2/ﬁo2), coagulation (platelets), liver (bilirubin), car-
diovascular (mean arterial pressure or administration of
vasopressors), central nervous system (Glasgow coma scale),
and renal (creatinine or urine output). Four levels of dysfunc-
tion are identiﬁed for each of the organ systems in the SOFA
score (184). In this study, SOFA scores were calculated every
48 during the hospital stay.
8. Statistical analysis
Pre-coded data were entered on the computer using ‘‘Micro-
soft Ofﬁce Excel Software” program (2010) for windows. Data
were then transferred to the Statistical Package of Social
Science Software (SPSS) program, version 21 (SPSS) to be sta-
tistically analyzed.
Data were summarized using mean and standard deviation
for quantitative variables and frequency, while percentage for
qualitative ones. Comparison between the studied groups was
performed using independent sample t-test for quantitative vari-
ables and Chi square or Fissure exact test for qualitative ones.
Repeated measurements were tested through paired t-test
or repeated measures ANOVA test, when suitable, in each
group separately.
Relative percent change was calculated as follows:
% change ¼ Post measure Premeasure
Premeasure
 100 ð1Þ
Pearson correlation coefﬁcients were calculated to signify
the associated between different quantitative variables in each
group separately. Kaplan–Meier test was performed to obtain
the median survival time. Receiver operating characteristics
(ROC) curve analysis was conducted to explore the discrimi-
nant ability of different parameters to differentiate the non
survivors. p values less than 0.05 and 0.01 were considered sta-
tistically signiﬁcant and highly signiﬁcant, respectively.
9. Results
Total eighty patients, meeting the inclusion criteria, were
prospectively studied. Among them 60 were male (75%) andthe rest were female (25%). The mean age of the patients
was 55.8 ± 17.0 years, ranging 20–86 years. The primary
sources of sepsis were chest and abdomen (47.5%, 25.0%,
respectively). The four most common isolated microorganisms
were Klebsiella (14.8%), Escherichia coli (12.4%), methicillin
resistant Staphylococcus aureus (12.4%) and Pseudomonas
(11.8%).
10. Laboratory investigations
10.1. Thyroid hormone levels
Onadmission, FT3 level within the normal range (1.7–4.5 pg/ml)
was found in 41 patients (51.2%), while the other 39 patients
(48.8%), had a FT3 level below the lower reference range. FT4
level within the normal reference range of (0.8–2 pmol/L) was
found in 53 patients (66.2%), while 27 patients (33.8%) had
fT4 levels below the lower reference range. TSH levels within
the normal reference range (0.3–5.5 uIU/ml) was found in 58
patients (72.5%), while 22 patients (27.5%) had TSH levels
below the lower reference range.
On the ﬁfth day FT3, fT4 and TSH levels below the refer-
ence range were found in 61.3%, 31.2% and 23.8% of patients
respectively. There was highly signiﬁcant difference between
low levels of FT3 on admission and the ﬁfth day (p< 0.001).
10.2. Level of FT3
We compared thyroid hormone levels among the patients of
three studied groups (sepsis, severe sepsis, and septic shock)
and found that the mean level of FT3 was lower in patients with
septic shock (1.3 ± 0.4 pg/ml) and severe sepsis (1.7 ± 0.2
pg/ml) as compared to patients with sepsis (2.4 ± 1.2 pg/ml)
with p value <0.001. However, no signiﬁcant difference was
observed in themean levels ofFT4 andTSHamong these studied
groups (Table 1).11. ICU mortality
The patients were followed up until discharged or death and
based on the outcome, they were divided into two groups: sur-
vivors (included 41 patients) and non survivors (included 39
patients). We found a signiﬁcant difference in the mean ages
of the patients between these two groups (survivor group:
46.3 ± 13.8 years, non survivor group: 65.7 ± 14.2 years;
p< 0.001).
There were 34 males and seven females in the survivor
group, while non survivors included 26 males and 13 females;
statistically no signiﬁcant difference in gender distribution was
58 M. Hosny et al.observed between the groups (p= 0.1) (Table 2). In survivors,
there were 36 patients (87.8%) with sepsis, 4 patients (11.2%)
with severe sepsis and one patient (1.8%) with septic shock. In
non survivors, there were 18 patients (46.2%) with severe sep-
sis and 21 patients (53.8%) with septic shock, but there were
no patients with sepsis. There was high signiﬁcant difference
between both groups (p< 0.001).
12. Microbiological analysis of both groups
There were several sources of infection (chest, abdomen, urine,
etc). The abdominal infection was the only source that showed
statistical signiﬁcant difference between survivors and non sur-
vivors (p= 0.04). It was diagnosed in fourteen patients of non
survivors (35.9%) and in six patients of survivors (14.6%).
As regarding the causative organism, methicillin resistant
S. aureus (MRSA) infection was higher in non survivors as
compared with survivors. There was high = statistical signiﬁ-
cant difference between both groups (p= 0.009). It was diag-
nosed in ten patients of non survivors (29.4%) and two
patients of survivors (5.1%) (Table 3).
13. Hematological and biochemical parameters
We found lower hemoglobin and albumin levels, but higher
TLC (total leukocyte count) among non survivors when com-
pared with survivors (Table 4).
No signiﬁcant difference was found in the mean levels of
the thyroid hormone on D1 as well. During follow up, we
observed a signiﬁcant increase in the mean FT3 level among
survivors, but a decrease among non survivors (p< 0.001);
however, other thyroid function tests did not show any signif-
icant difference between both groups (Table 5).
High signiﬁcant difference in the percentage change
between FT3 on D1 and D5 was observed between the two
groups (survivors: 53.8 ± 56.8, non survivors: 45.8 ± 19.9;
p< 0.001); however, there was no signiﬁcant difference in
the percentage changes of FT4 and TSH between both groups
(p= 0.1 and 0.6, respectively) (Table 6).
While no signiﬁcant difference was found in median CRP
level (p= 0.3) on D1, high signiﬁcant difference was observed
in the median CRP level (p< 0.001) on D5 with non survivors
showing a higher value.
Interleukin-6 (IL-6) level was used as a marker of inﬂam-
matory response. All patients showed high interleukin 6
(IL6) conﬁrming sepsis. The mean level of IL6 on admission
was higher in non survivors than survivors, and a highly signif-
icant difference was found between two groups (p< 0.001)
(Table 7).Table 2 Age, sex and co morbidities in both groups.
Survivors Non survivors p value
Number (%) 41 (51.2%) 39 (48.8%)
Age in years (Mean ± SD) 46.3 ± 13.8 65.7 ± 14.2 <0.001
Sex Males 34 26 0.1
Female 7 13
Hypertension 20 (48.7%) 24 (61.5%) 0.56
Diabetes 5 (12%) 5 (13%) 0.77
IHD 4 (9.7%) 4 (10.2%) 0.4614. ICU mortality calculator: APACHE and SOFA scores
The mean APACHE (Acute Physiologic and Chronic Health
Evaluation) and SOFA (Sequential Organ Failure Assessment)
scores were higher in non survivors than survivors. There was
highly signiﬁcant difference between both groups (p< 0.001).
The median estimate survival time among the septic patients
was 20 days (ranging between 15.1 days and 24.9 days) with
95% conﬁdence interval (CI) (Table 8).
There was highly signiﬁcant difference in the duration of
MV and ICU stay between survivors and non survivors
(p< 0.005 and 0.001 respectively) (Table 9).
15. Correlation between FT3 on D5 with other parameters within
non survivors
We found signiﬁcant negative correlations between FT3D5,
CRP, IL-6, APACHE and SOFA scores. In addition, FT3
levels on D5 were also negatively correlated with the duration
of mechanical ventilation and ICU stay (Table 10).
Receiver operating characteristic (ROC) curves were con-
structed to examine the performance of indicators as predic-
tors of ICU mortality; the area under the curve (AUC) for
each indicator was calculated. In the case of thyroid function
tests, the FT3 D5 level with largest AUC (0.855) was the best
in predicting ICU mortality (p< 0.001, sensitivity 87.2%, and
speciﬁcity 73.2%).
CRP (AUC= 0.984, p< 0.001, sensitivity 100%, and
speciﬁcity 92.7%) emerged as a better tool than IL-6
(AUC= 0.934, p< 0.001, sensitivity 92.3%, and speciﬁcity
80.5%) for predicting the mortality in septic patients.
Between the two scoring systems, we found the SOFA score
(AUC= 1, p< 0.001, sensitivity 100%, and speciﬁcity 100%)
was the better tool for predicting the mortality in septic patients
than the APACHE score (AUC= 0.975, p< 0.001, sensitivity
94.4%, and speciﬁcity 92%) (Table 11 and Figs. 1 and 2).
16. Discussion
The role of euthyroid sick syndrome (ESS) as a predictor of
poor outcome in sepsis and critical illness remains unclear.
This inspires us to undertake the current study on septic
patients to assess the relation between thyroid function tests,
CRP, IL-6, and ICU mortality scores (APACHE and SOFA
scores) as predictors of mortality.
We ﬁrst divided 80 enrolled patients into three groups as
sepsis (36 patients), severe sepsis (23 patients), and septic shock
(21 patients) groups. Based on the outcome of the follow-up,
these 80 patients were again divided into two groups as sur-
vivors (41 patients) and non survivors (39 patients).
Our biomarker data did not show any difference in circulat-
ing thyroid hormone levels (FT3, FT4 and TSH) measured on
admission among survivors and non-survivors, thus, failed to
provide any helpful prognostic information. During follow
up (D5), only the mean FT3 was signiﬁcantly decreased in
non survivors (1 ± 0.65 pg/ml), while it increased in survivors
(2.9 ± 1.03 pg/ml) (p< 0.001). The mean serum FT3 was
lower in patients with septic shock (1.3 ± 0.4 pg/ml) and sev-
ere sepsis (1.7 ± 0.2 pg/ml) as compared to patients with sepsis
(2.4 ± 1.2 pg/ml), while other thyroid indicators did not show
any signiﬁcant difference.
Table 3 Sources of infection and causative organisms in both groups.
Sources of infection Chest Abdomen Blood Skin Urine Heart Others
Survivor no
%
17
41.5%
6
14.6%
2
4.9%
8
9.5%
12
29.3%
1
2.4%
Non survivors no
%
21
53.8%
14
35.9%
7
17.9%
6
15.4%
5
12.8%
1
2.6%
p value 0.4 0.04 0.08 0.8 0.1 1.0
Causative organism Klebsiella E. coli MRSA Pseudomonas Streptococci Acinetobacter Others
Survivor no
%
4
10.2%
5
12.8%
2
5.1%
2
12.2%
6
9.7%
3
7.3%
8
20%
Non survivors no
%
9
22%
7
17.1%
10
24.4%
6
15.3%
2
10.2%
3
7.7%
9
22.1%
p value 0.2 0.8 0.009 0.062 0.1 0.1 0.5
Table 4 Basic laboratory investigations of both groups.
Survivors
Mean ± SD
Non survivors
Mean ± SD
p value
TLC 13.2 ± 1.2 20.0 ± 10.1 <0.001
HB 10.1 ± 1.1 7.2 ± 0.5 <0.001
Albumin 3.0 ± 0.6 1.7 ± 0.3 <0.001
Table 5 Thyroid hormone levels of both groups.
Survivors
Mean ± SD
Non survivors
Mean ± SD
p value
FT3 D1 2.00 ± 0.87 1.9 ± 0.98 0.7
FT3 D5 2.9 ± 1.03 1.0 ± 0.65 <0.001
FT4 D1 1.15 ± 0.39 1.13 ± 0.42 0.2
FT4 D5 1.12 ± 0.41 1.13 ± 0.42 1
TSH D1 0.92 ± 0.90 0.91 ± 1.08 1
TSH D5 1.01 ± 0.96 0.91 ± 0.96 0.7
Table 6 Percentage change of FT3, FT4 and TSH of both
groups.
Survivors
Mean ± SD
Non survivors
Mean ± SD
p value
FT3% change 53.8 ± 56.8 45.8 ± 19.9 <0.001
FT4% change 5.4 ± 13.2 0.2 ± 12.6 0.1
TSH% change 25.4 ± 141.8 60.4 ± 305.4 0.6
Table 7 C-reactive protein and IL6 level of both groups.
Survivors median
(interquartile
range)
Non survivors
median (interquartile
range)
p value
CRP D1 42 (28.5–96) 48 (15–60) 0.3
CRP D5 12 (6–15) 170 (109–205) <0.001
Survivors
Mean ± SD
Non survivors
Mean ± SD
p value
IL-6 35.7 ± 34.7 231.3 ± 178.4 <0.001
Table 8 APACHE II and SOFA scores of both groups.
Survivors
Mean ± SD
Non survivors
Mean ± SD
p value
APACHE 10.3 ± 3.2 26.6 ± 7 <0.001
SOFA Day 2 2.7 ± 1.6 14 ± 2.8 <0.001
SOFA Day 5 0.9 ± 0.9 17.4 ± 3 <0.001
Table 9 Duration of mechanical ventilation (MV) and ICU
stay of both groups.
Survivors
Mean ± SD
Non survivors
Mean ± SD
p value
Duration of MV 5.1 ± 5.2 17.6 ± 16.0 <0.005
Length of ICU stay 8.2 ± 4.4 21.4 ± 18.8 <0.001
Predictive value of thyroid hormone assessment in septic patients 59Meyer et al. [13] assessed the prognostic accuracy of thyroid
hormone levels in 103 septic patients on admission and during
follow up and found no difference in FT3 and FT4 levels on
admission in non survivors when compared with survivors.
The lowest FT3 level was found in patients with severe sepsis
(0.8 nmol/l) and septic shock (0.8 nmol/l), which is in agree-
ment with our ﬁndings. However, in the same study during fol-
low up, they found that the FT4 level decreased signiﬁcantly in
non survivors, while it increased in survivors (p 0.003); our
ﬁndings differ in this regard and the difference could be attrib-
uted to the time of measurement of the thyroid hormone,
Meyer et al. measured the thyroid hormone on admission,the second day and at discharge, while the thyroid hormone
was measured on admission and ﬁfth day in this study.
In a systematic review on association between thyroid func-
tion tests at the baseline and the outcome of patients with sep-
sis or septic shock, Anna et al. [14] included nine studies, all
having a prospective cohort design. Seven of those studies
involved children, while two involved adults. Six of the nine
included studies disagreed with our results and showed that
FT3 and FT4 on admission were lower in patients with sepsis
who had an unfavorable outcome than in those who had a favor-
able outcome, while the remaining studies came in agreement
Table 10 Correlation between FT3 D5 with other parameters
within non survivors.
FT3 Day 5
R p
CRP 0.332 0.039
IL6 0.339 0.035
APACHE 0.359 0.025
SOFA 0.427 0.007
Duration of MV 0.333 0.033
Duration of ICU stay 0.478 0.002
Table 11 Value of indicators in predicting ICU mortality.
Variables AUC Cut oﬀ Sensitivity (%) Speciﬁcity (%) p value
FT3 D1 0.748 P2.15 79.5 70.7 0.07
FT3 D5 0.855 62.15 87.2 73.2 <0.001
FT4 D1 0.573 P0.81 74.93 71.46 0.258
FT4 D5 0.612 0.081 72.53 70.33 0.085
TSH D1 0.573 P0.3 1 70.52 70.2 0.254
TSH D5 0.564 60.3 1 68.04 64.79 0.321
CRP 0.984 P72 100 92.7 <0.001
IL6 0.934 P59.6 92.3 80.5 <0.001
APACHE 0.975 P15 94.4 90.2 <0.001
SOFA 1.00 P7 100 100 <0.001
Figure 1 The ROC curve of FT3D5.
Figure 2 The ROC curve of APACHE, SOFA scores, CRP and
IL-6.
60 M. Hosny et al.with our results. They concluded that FT3 and FT4 levels on
admission are not helpful in predicting outcome in sepsis.
In our study, low FT3 level on the ﬁfth day was the only
independent predictor of mortality among the thyroid function
tests, as indicated by the largest AUC of 0.855. The AUC for
the FT3 level (0.855) was less than that for APACHE (0.975)
and SOFA scores (1.00). We found a signiﬁcant negative cor-
relation between FT3 on D5 and ICU predicting mortality
scores (FT3 on D5 and APACHE score, p= 0.025; FT3 on
D5 and SOFA score, p= 0.007). We suggest that the addition
of the FT3 level to the APACHE II and SOFA scores might
improve the ability to predict ICU mortality.Wang et al. [15] investigated the relation between the thy-
roid hormone and APACHE in 480 critical illness patients
including sepsis, and reported similar ﬁndings as observed by
us. They found that FT3 was the best among the thyroid hor-
mone indicators for predicting ICU mortality, as suggested by
the largest AUC of 0.762. The AUC for the FT3 level was less
than that for APACHE II score (0.829 ± 0.022). The level of
FT3 was signiﬁcantly correlated with the APACHE score
(p< 0.001). Ture et al. [16] measured thyroid hormones within
the ﬁrst 24 h in 206 patients with acute respiratory distress syn-
drome and found that serum FT3 concentrations markedly
decreased after ICU admission among non survivors. There
was high signiﬁcant and negative correlation between FT3and
ICU mortality scores (for APACHE II score p< 0.0005 and
for SOFA scores p< 0.0005).
Our study is in agreement with the ﬁndings by Elvio et al.
[17], who studied 32 consecutive patients with respiratory fail-
ure including pneumonia and observed that plasma fT3 was
correlated with PaO2/FiO2 (p= 0.001) and APACHE II score
(p= 0.003). Among non survivors, FT3 levels were signiﬁ-
cantly lower (p= 0.002) compared to the survivors.
We observed that the mean CRP increased signiﬁcantly
from D1 to D5 in non survivors (from 53.9 ± 50 mg/l to
162.2 ± 55 mg/l), while it decreased signiﬁcantly from D1 to
D5 in survivors (from 63.8 ± 48 mg/l to 19.1 ± 25.7 mg/l)
with a high signiﬁcant difference (p< 0.001). This suggests
that decreasing or increasing values of CRP may be used as
a predictor of outcome in patients with sepsis. In this regard,
the ﬁndings by Povoa et al. [3] are in agreement with our ﬁnd-
ings. They studied 891 consecutive patients of community
acquired sepsis and found that CRP was signiﬁcantly higher
in non survivors. In another study by Povoa et al. [18], the
daily C-reactive protein measurement after antibiotic prescrip-
tion was found to be useful in identifying ventilator-associated
pneumonia (VAP) patients with poor outcome.
In the present prospective study, all patients showed high
interleukin-6 (IL-6) levels, conﬁrming sepsis. Non survivors
hadhigher IL-6 levels (231.3 ± 178.4 pg/ml) as compared to sur-
vivors (35.7 ± 34.7 pg/ml).There was high signiﬁcant difference
between both groups (p< 0.001), suggesting that the IL-6 level
can be used as a marker for diagnosis and prognosis of sepsis.
Predictive value of thyroid hormone assessment in septic patients 61In their study, Zhenyu et al. [19] divided 102 patients with
sepsis into survival and non survival groups. Serum IL-6 level
was measured on admission to ICU. The authors found that
serum IL-6 levels of patients in the non survival group of sepsis
were signiﬁcantly higher than those in the survival group
(p< 0.01).
We observed lower FT3 on day 5 with higher CRP and IL-6
in non survivors and FT3 D5 level was also negatively corre-
lated with CRP (p= 0.039) and IL-6 (p= 0.035). The AUC
for FT3 (0.855) was less than for CRP (0.984) and IL-6
(0.934). Hence, the FT3 had less ability than IL-6 and CRP
in predicting mortality in sepsis.
Our ﬁndings are also in accordance with the results
obtained by Dilli and Dilmen [20]. They determined the rela-
tion between FT3, CRP and IL-6 levels in 148 infants with sep-
sis. The Serum FT3 was negatively and strongly correlated
with IL-6 (r= 0.49, p= 0.001) and CRP (r= 0.33,
p= 0.03). The mortality rate was higher among infants with
lower FT3 levels. This can be explained based on the fact that
CRP is induced by cytokines (especially by IL-6) and produced
in the liver, whereas iodothyronine50-deiodinase, mediating the
conversion of T3 from T4, is also found in rich quantities in
the liver. It is possible that IL-6 stimulates the production of
CRP as well as inhibits50-deiodinase.
Our results suggest that FT3 level is the only predictor of
mortality among all components of the thyroid hormone.
We found CRP, an inﬂammatory mediator, showing a signiﬁ-
cant prognostic value in predicting the mortality in septic
patients when compared to that in IL-6 and FT3 levels.
The current study has a few limitations. Firstly, we mea-
sured serum IL-6 levels only on the day of admission; follow
up of IL-6 might have improved validity of the results. Sec-
ondly, patients in ICU receive many drugs that may affect
the level of the thyroid hormone; twenty ﬁve patients, who
were excluded from this study, ﬁfteen of them received dopa-
mine, while the rest received amiodarone and phenytoin.17. Conclusions and recommendation
The objective of our study was to ﬁnd whether the thyroid hor-
mone has any prognostic value in predicting mortality among
sepsis patients. FT3 measured on ﬁfth day of admission came
out as the only independent predictor of ICU mortality.
Although SOFA score was the best predictor of mortality fol-
lowed by APACHE score, CRP, tIL-6 levels, and FT3 D5, we
still recommend FT3 to be used as a predictor of mortality in
sepsis as this is the only independent predictor for ICU
mortality.
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